Navigation Links
Biomet Hip Replacement Claims: Bernstein Liebhard LLP Looks Ahead to Next Case Management Conference in Federal Litigation of Biomet Hip Lawsuits
Date:6/9/2013

New York, NY (PRWEB) June 09, 2013

Bernstein Liebhard LLP notes the scheduling of an upcoming status conference in the federal litigation of Biomet hip replacement claims established in the Northern District of Indiana.

Court records indicate that the next Case Management Conference in the proceeding will be held on June 17th at 9:30 a.m.* Claims pending in this multidistrict litigation have been filed on behalf of individuals who allegedly suffered injuries stemming from the Biomet M2a Magnum Hip Replacement System. According to Biomet hip lawsuits, the metal-on-metal design of the Biomet M2a Magnum implant can generate high metal ion levels, which may cause patients to suffer metallosis and other adverse tissue reactions indicating early failure of the device. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

“Our Firm continues to hear from Biomet hip replacement recipients who have allegedly experienced horribly painful complications associated with the metal-on-metal implant. Our lawyers are already representing individuals in this federal litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to individuals who may have been injured by the Biomet M2a Magnum hip replacement.

Biomet Hip Lawsuits
As of May 2013, more than 140 Biomet hip lawsuits had been filed in the federal multidistrict litigation underway in the U.S. District Court, Northern District of Indiana. These lawsuits allege pain, swelling, loosening of the implant and other complications associated with early hip failure.

As the number of claims involving the Biomet M2a Magnum hip continues to grow in federal court, its manufacturer is in the midst of collecting data for two studies assessing the safety of the metal-on-metal implant. According to a notice posted November 6, 2012 on clinicaltrials.gov, Biomet is enrolling individuals who received the M2a Magnum hip in an observational study to examine adverse tissue reactions that may have been experienced after initial implantation.** The study, which was launched in cooperation with a 2011 surveillance order from the U.S. Food and Drug Administration (FDA) requiring all metal-on-metal hip manufacturers to conduct safety studies on their products, is expected to be completed in December 2014.

Additionally, clinicaltrials.gov published an update on March 6, 2013 regarding another metal hip safety study currently being conducted by Biomet. According to a notice, the company is no longer recruiting participants for a study that has been underway in Japan since 2009.***According to clinicaltrials.gov, final data for the study will be collected in December 2013, and the study is expected to reach completion by December 2021.

Individuals who received the Biomet M2a Magnum hip and allegedly suffered injuries as a result of the device may be entitled to compensation for additional medical expenses, lost wages and pain and suffering. Learn more about the complications associated with metal-on-metal hip implants by visiting Bernstein Liebhard LLP’s website or by calling one our attorneys today at 800-511-5092.

*innd.uscourts.gov/millermdl2391.asp
**clinicaltrials.gov/ct2/show/NCT01750606?term=NCT01750606&rank=1
***clinicaltrials.gov/ct2/show/NCT01010763?term=Biomet+M2a+Japan&rank=1

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/Biomet-hip-replacement/Biomet-hip-lawsuits/prweb10814224.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Has Added Wright, Stryker, Biomet, and Zimmer To Their Initiative For All Metal Hip Implant Failures Victims & Offers Them The Names Of The Best Lawyers
2. US Drug Watchdog Now Offers DePuy, Stryker, Biomet, Zimmer, and Wright All Metal Hip Implant Failure Victims the Names of the Best Law Firms-Don't Get Left Holding the Bag
3. US Drug Watchdog Now Offers Recipients Of A DePuy, Wright, Stryker, Biomet or Zimmer Metal on Metal Hip Implant The Names of the Best Law Firms If Their Hip Has Failed
4. US Drug Watchdog Now Urges All Zimmer, Stryker, Biomet, Wright and DePuy Metal Hip Implant Recipients to Get Blood Tests
5. US Drug Watchdog Now Urges All Zimmer Stryker, Biomet, Wright and DePuy All Metal Hip Implant Recipients to Get A Blood Test For A Failure-Don't Get Left Holding the Bag
6. MinuteHound News: Top Three Ways To Save Money With Biometric Time and Attendance Solutions
7. Law Firm Issues Biomet Hip Infographic Warning Consumers About the Dangers of Biomet Hip Implants
8. MinuteHound Annouces Top 5 Reasons Businesses Increasingly Switching To Biometrics
9. MinuteHound Releases Time Clock Software Featuring Secure Biometric Technology for Business Applications
10. Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Biomet Hip Litigation
11. Biomet Hip Lawsuit: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Biomet Hip Replacement Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine named Herr ... field of biomechatronics, technology that marries human physiology with electromechanics. He continues that work ... also the Founder of BionX , a leader in the field of prosthetic ...
(Date:4/28/2016)... ... April 28, 2016 , ... One way to ignore solid evidence is ... true. But we toss the baby out with the bathwater when we ignore all ... identifying higher-quality studies and otherwise making better use of education policy research. , “When ...
(Date:4/28/2016)... ... April 28, 2016 , ... Anzu®, ... announced a new Residency Education & Collaboration Platform for hospitals and medical ... and a host of collaboration tools designed to improve patient outcomes through ...
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission for Health Care ... (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction in Oncology. This ... ACHC provides a wide range of pharmacy accreditation services that assess the business ...
(Date:4/28/2016)... MO (PRWEB) , ... April 28, 2016 , ... Denise McCormick Baich had written poetry ... 2009 the poetry arrived again much like a tsunami and took on a more spiritual ... to her encouraged her to do more with it than just file it away. Friends ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... , April 27, 2016 Transparency ... "Skincare Devices Market - Global Industry Analysis, Size, Share, ... the report, the global skincare devices market was valued ... to expand at a CAGR of 10.1% from 2015 ... Browse the full Skincare Devices Market (Treatment Device ...
(Date:4/27/2016)... Kan. , April 27, 2016  Bayer ... , a senior from the University of Florida ... of the Bayer Excellence in Communication Award (BECA). ... schools, which were awarded a total of $70,000 ... the last four years, Bayer has provided a ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
Breaking Medicine Technology: